title: Erythropoietin stimulating agents do not significantly improve quality of life in chronic kidney disease, study finds.
authors.forename: Michael
authors.initials: M
authors.lastname: McCarthy
mesh_terms: D000740:Anemia / Q000188:drug therapy*; D006397:Hematinics / Q000627:therapeutic use*; D006801:Humans; D011788:Quality of Life; D051436:Renal Insufficiency, Chronic / Q000150:complications*
chemical_list: D006397:Hematinics